Triple
T1428853
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Health Resources and Services Administration |
E30396
|
entity |
| Predicate | oversees |
P46
|
FINISHED |
| Object |
340B Drug Pricing Program
The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
|
E163275
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: 340B Drug Pricing Program | Statement: [Health Resources and Services Administration, oversees, 340B Drug Pricing Program]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: 340B Drug Pricing Program Context triple: [Health Resources and Services Administration, oversees, 340B Drug Pricing Program]
-
A.
Prescription Drug Take Back Program
The Prescription Drug Take Back Program is a U.S. Drug Enforcement Administration initiative that provides safe, convenient, and responsible ways for the public to dispose of unused or expired prescription medications.
-
B.
Center for Medicare and Medicaid Innovation
The Center for Medicare and Medicaid Innovation is a federal agency within CMS that tests and implements new payment and service delivery models to improve quality and reduce costs in Medicare, Medicaid, and CHIP.
-
C.
NIDA Drug Supply Program
The NIDA Drug Supply Program is a U.S. government initiative that provides researchers with controlled substances and related materials to support scientific studies on drug abuse and addiction.
-
D.
Ryan Haight Online Pharmacy Consumer Protection Act of 2008
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 is a U.S. federal law that regulates internet pharmacies by requiring valid prescriptions and in-person medical evaluations before dispensing controlled substances online.
-
E.
Medicare Part D
Medicare Part D is the U.S. federal program that provides outpatient prescription drug coverage to Medicare beneficiaries through private insurance plans.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: 340B Drug Pricing Program Triple: [Health Resources and Services Administration, oversees, 340B Drug Pricing Program]
Generated description
The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: 340B Drug Pricing Program Target entity description: The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
-
A.
Prescription Drug Take Back Program
The Prescription Drug Take Back Program is a U.S. Drug Enforcement Administration initiative that provides safe, convenient, and responsible ways for the public to dispose of unused or expired prescription medications.
-
B.
Center for Medicare and Medicaid Innovation
The Center for Medicare and Medicaid Innovation is a federal agency within CMS that tests and implements new payment and service delivery models to improve quality and reduce costs in Medicare, Medicaid, and CHIP.
-
C.
NIDA Drug Supply Program
The NIDA Drug Supply Program is a U.S. government initiative that provides researchers with controlled substances and related materials to support scientific studies on drug abuse and addiction.
-
D.
Ryan Haight Online Pharmacy Consumer Protection Act of 2008
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 is a U.S. federal law that regulates internet pharmacies by requiring valid prescriptions and in-person medical evaluations before dispensing controlled substances online.
-
E.
Medicare Part D
Medicare Part D is the U.S. federal program that provides outpatient prescription drug coverage to Medicare beneficiaries through private insurance plans.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a498fb823c8190a67ce4c4837e641a |
completed | March 1, 2026, 7:52 p.m. |
| NER | Named-entity recognition | batch_69a4c4d9575881908bb58598e5a80590 |
completed | March 1, 2026, 10:59 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ad016930ec8190ab3900d6f40c4aa0 |
completed | March 8, 2026, 4:56 a.m. |
| NEDg | Description generation | batch_69ad01d1c01c81908917c4837ed2b393 |
completed | March 8, 2026, 4:57 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69ad0265f610819085a2dd293abd4812 |
completed | March 8, 2026, 5 a.m. |
Created at: March 1, 2026, 8 p.m.